ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$11.61
-0.23 (-1.94%)
Open$11.76
Previous Close$11.84
Day High$11.93
Day Low$11.52
52W High$15.04
52W Low$7.16
Volume—
Avg Volume916.8K
Market Cap713.20M
P/E Ratio12.24
EPS$0.97
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-54.0% upside
Current
$11.61
$11.61
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 112.38M | 30.86M | 109.96M |
| Net Income | 87.85M | -124,101,933 | 24.47M |
| Profit Margin | 78.2% | -424.5% | 22.3% |
| EBITDA | -62,157,123 | -97,531,026 | 54.29M |
| Free Cash Flow | — | — | 22.49M |
| Rev Growth | +116.7% | -6.2% | -4.5% |
| Debt/Equity | 0.40 | 1.50 | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |